Multiple choice

Match the column - I with column – II and select the correct option ||| |---|---| |Column – I |Column – II| |P. Polymerase chain reaction|1. for monoclonal antibody production| |Q. Ti plasmid|2. for breaking bond between insulin and galactosidase| |R. CNBr|3. for introducing foreign genes into plants| |S. Hybridoma technology|4. for gene amplification|

  1. P - 1, Q - 2, R - 3, S - 4

  2. P - 2, Q - 1, R - 4, S - 3

  3. P - 3, Q - 2, R - 1, S - 4

  4. P - 4, Q - 3, R - 2, S - 1

  5. P - 1, Q - 2, R - 4, S - 3

Reveal answer Fill a bubble to check yourself
D Correct answer
Explanation

Hybridoma is a cell that is produced in the laboratory from the fusion of an antibody-producing lymphocyte and a nonantibody-producing cancer cell, usually a myeloma or lymphoma. It proliferates and produces a continuous supply of a specific monoclonal antibody. During recombinant insulin synthesis, the bond between insulin polypeptide and galactosidase can be removed by using cyanogen bromide. The Ti plasmid (tumor-inducing plasmid) of Agrobacterium tumefaciens has been developed as a vehicle for introducing foreign genes into plants. Polymerase Chain Reaction (PCR), is a technology used for amplifying DNA sequences.